-
公开(公告)号：US20180030131A1
公开(公告)日：2018-02-01
申请号：US15783289
申请日：2017-10-13
Applicant: Cephalon, Inc.
Inventor： Christopher Obrien , James Zangrilli , Tushar Shah , Guy Brusselle
Abstract: Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to the patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/μL.
Search Results
1
records
(took 0.02 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
